Challenge of informing patient decision making what can we tell patients considering long-term mechanical circulatory support about outcomes, daily life, and end-of-life issues?

Circulation: Cardiovascular Quality and Outcomes

Volumn 7, Issue 1, 2014, Pages 179-187

  Boothroyd, Lucy J ^a   Lambert, Laurie J ^a   Ducharme, Anique ^b   Guertin, Jason R ^c   Sas, Georgeta ^a   Charbonneau, Éric ^d   Carrier, Michel ^b   Cecere, Renzo ^e   Morin, Jean E ^e   Bogaty, Peter ^d  

^a Institute national d'excellence en santé et services sociaux   (Canada)

^b MONTREAL HEART INSTITUTE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Decision support techniques; Heart failure; Heart assist devices

Indexed keywords

ASSISTED CIRCULATION; FUNCTIONAL STATUS; HUMAN; LIFE EXPECTANCY; LONG TERM CARE; MECHANICAL CIRCULATORY SUPPORT; MEDICAL INFORMATION; MEDICAL LITERATURE; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SURVIVAL; TERMINAL CARE;

DECISION SUPPORT TECHNIQUES; HEART FAILURE; HEART-ASSIST DEVICES;

ACTIVITIES OF DAILY LIVING; COMMUNICATION; DECISION MAKING; HEART DISEASES; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; INFORMED CONSENT; PATIENT PARTICIPATION; PHYSICIAN-PATIENT RELATIONS; RISK ASSESSMENT; TERMINAL CARE; TREATMENT OUTCOME;

EID: 84898748126     PISSN: 19417713     EISSN: 19417705     Source Type: Journal    
DOI: 10.1161/CIRCOUTCOMES.113.000243     Document Type: Review

References (42)

1. Institut National d'Excellence en Santé et en Services Sociaux. Évaluation des données probantes sur les dispositifs d'assistance ventriculaire gauche HeartMate II® et HeartWare® pour le traitement de l'insuffisance cardiaque chronique terminale. Montreal, Canada: INESSS; 2012. www. inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Cardio/ETMIS2012-Vol8-No15.pdf. Accessed December 18, 2013
2. Allen LA, Stevenson LW, Grady KL, Goldstein NE, Matlock DD, Arnold RM, Cook NR, Felker GM, Francis GS, Hauptman PJ, Havranek EP, Krumholz HM, Mancini D, Riegel B, Spertus JA; American Heart Association; Council on Quality of Care and Outcomes Research; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Surgery and Anesthesia. Decision making in advanced heart failure: a scientific statement from the American Heart Association. Circulation. 2012;125:1928-1952
3. Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, Morgan JA, Arabia F, Bauman ME, Buchholz HW, Deng M, Dickstein ML, El-Banayosy A, Elliot T, Goldstein DJ, Grady KL, Jones K, Hryniewicz K, John R, Kaan A, Kusne S, Loebe M, Massicotte MP, Moazami N, Mohacsi P, Mooney M, Nelson T, Pagani F, Perry W, Potapov EV, Eduardo Rame J, Russell SD, Sorensen EN, Sun B, Strueber M, Mangi AA, Petty MG, Rogers J; International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157-187
4. Dudzinski DM. Ethics guidelines for destination therapy. Ann Thorac Surg. 2006;81:1185-1188
5. Rizzieri AG, Verheijde JL, Rady MY, McGregor JL. Ethical challenges with the left ventricular assist device as a destination therapy. Philos Ethics Humanit Med. 2008;3:20
6. Petrucci RJ, Benish LA, Carrow BL, Prato L, Hankins SR, Eisen HJ, Entwistle JW. Ethical considerations for ventricular assist device support: a 10-point model. ASAIO J. 2011;57:268-273
7. Paterick TJ, Carson GV, Allen MC, Paterick TE. Medical informed consent: general considerations for physicians. Mayo Clin Proc. 2008;83:313-319
8. Kirkpatrick JN, Fedson SE, Verdino R. Ethical dilemmas in device treatment for advanced heart failure. Curr Opin Support Palliat Care. 2007;1:267-273
9. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241-2251
10. Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, Steidley DE, Ewald GA, Sundareswaran KS, Farrar DJ, Slaughter MS; HeartMate II Clinical Investigators. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5:241-248
11. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS; HeartMate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol. 2010;55:1826-1834
12. Hasin T, Marmor Y, Kremers W, Topilsky Y, Severson CJ, Schirger JA, Boilson BA, Clavell AL, Rodeheffer RJ, Frantz RP, Edwards BS, Pereira NL, Stulak JM, Joyce L, Daly R, Park SJ, Kushwaha SS. Readmissions after implantation of axial flow left ventricular assist device. J Am Coll Cardiol. 2013;61:153-163
13. Petrucci RJ, Rogers JG, Blue L, Gallagher C, Russell SD, Dordunoo D, Jaski BE, Chillcott S, Sun B, Yanssens TL, Tatooles A, Koundakjian L, Farrar DJ, Slaughter MS. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support. J Heart Lung Transplant. 2012;31:27-36
14. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA, Timothy Baldwin J, Young JB. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32:141-156
15. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M, Young JB. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg. 2012;144:584-603; discussion 597
16. Hrobowski T, Lanfear DE. Ventricular assist devices: is destination therapy a viable alternative in the non-transplant candidate? Curr Heart Fail Rep. 2013;10:101-107
17. Pagani FD, Miller LW, Russell SD, Aaronson KD, John R, Boyle AJ, Conte JV, Bogaev RC, MacGillivray TE, Naka Y, Mancini D, Massey HT, Chen L, Klodell CT, Aranda JM, Moazami N, Ewald GA, Farrar DJ, Frazier OH; HeartMate II Investigators. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312-321
18. Starling RC, Naka Y, Boyle AJ, Gonzalez-Stawinski G, John R, Jorde U, Russell SD, Conte JV, Aaronson KD, McGee EC Jr, Cotts WG, DeNofrio D, Pham DT, Farrar DJ, Pagani FD. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). J Am Coll Cardiol. 2011;57:1890-1898
19. McKelvie RS, Moe GW, Cheung A, Costigan J, Ducharme A, Estrella- Holder E, Ezekowitz JA, Floras J, Giannetti N, Grzeslo A, Harkness K, Heckman GA, Howlett JG, Kouz S, Leblanc K, Mann E, O'Meara E, Rajda M, Rao V, Simon J, Swiggum E, Zieroth S, Arnold JM, Ashton T, D'Astous M, Dorian P, Haddad H, Isaac DL, Leblanc MH, Liu P, Sussex B, Ross HJ. The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care. Can J Cardiol. 2011;27:319-338
20. Goodlin SJ, Hauptman PJ, Arnold R, Grady K, Hershberger RE, Kutner J, Masoudi F, Spertus J, Dracup K, Cleary JF, Medak R, Crispell K, Piña I, Stuart B, Whitney C, Rector T, Teno J, Renlund DG. Consensus statement: palliative and supportive care in advanced heart failure. J Card Fail. 2004;10:200-209
21. Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant. 2009;28:827-833
22. Bonde P, Ku NC, Genovese EA, Bermudez CA, Bhama JK, Ciarleglio MM, Cong X, Teuteberg JJ, Kormos RL. Model for end-stage liver disease score predicts adverse events related to ventricular assist device therapy. Ann Thorac Surg. 2012;93:1541-1547; discussion 1547
23. Grady KL, Warner Stevenson L, Pagani FD, Teuteberg J, Pamboukian SV, Birks E, Moore S, Kirklin JK. Beyond survival: recommendations from INTERMACS for assessing function and quality of life with mechanical circulatory support. J Heart Lung Transplant. 2012;31:1158-1164
24. Allen LA, Gheorghiade M, Reid KJ, Dunlay SM, Chan PS, Hauptman PJ, Zannad F, Konstam MA, Spertus JA. Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes. 2011;4:389-398
25. Eshelman AK, Mason S, Nemeh H, Williams C. LVAD destination therapy: applying what we know about psychiatric evaluation and management from cardiac failure and transplant. Heart Fail Rev. 2009;14:21-28
26. Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, John R, Kiernan MS, Mitchell JE, O'Connell JB, Pagani FD, Petty M, Ravichandran P, Rogers JG, Semigran MJ, Toole JM; American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation; Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126:2648-2667
27. Goldstein NE, May CW, Meier DE. Comprehensive care for mechanical circulatory support: a new frontier for synergy with palliative care. Circ Heart Fail. 2011;4:519-527
28. Casida JM, Marcuccilli L, Peters RM, Wright S. Lifestyle adjustments of adults with long-term implantable left ventricular assist devices: a phenomenologic inquiry. Heart Lung. 2011;40:511-520
29. Zambroski CH, Combs P, Cronin SN, Pfeffer C. Edgar Allan Poe, "The pit and the pendulum," and ventricular assist devices. Crit Care Nurse. 2009;29:29-39
30. Marcuccilli L, Casida JM. From insiders' perspectives: adjusting to caregiving for patients with left ventricular assist devices. Prog Transplant. 2011;21:137-143
31. Marcuccilli L, Casida JJ, Peters RM, Wright S. Sex and intimacy among patients with implantable left-ventricular assist devices. J Cardiovasc Nurs. 2011;26:504-511
32. Casida JM, Davis JE, Brewer RJ, Smith C, Yarandi H. Sleep and daytime sleepiness of patients with left ventricular assist devices: a longitudinal pilot study. Prog Transplant. 2011;21:131-136
33. Casida JM, Brewer RJ, Smith C, Davis JE. An exploratory study of sleep quality, daytime function, and quality of life in patients with mechanical circulatory support. Int J Artif Organs. 2012;35:531-537
34. Heilmann C, Kuijpers N, Beyersdorf F, Berchtold-Herz M, Trummer G, Stroh AL, Schlensak C, Fritzsche K. Supportive psychotherapy for patients with heart transplantation or ventricular assist devices. Eur J Cardiothorac Surg. 2011;39:e44-e50
35. Mueller PS, Swetz KM, Freeman MR, Carter KA, Crowley ME, Severson CJ, Park SJ, Sulmasy DP. Ethical analysis of withdrawing ventricular assist device support. Mayo Clin Proc. 2010;85:791-797
36. Bramstedt KA, Wenger NS. When withdrawal of life-sustaining care does more than allow death to take its course: the dilemma of left ventricular assist devices. J Heart Lung Transplant. 2001;20:544-548
37. Jaarsma T, Beattie JM, Ryder M, Rutten FH, McDonagh T, Mohacsi P, Murray SA, Grodzicki T, Bergh I, Metra M, Ekman I, Angermann C, Leventhal M, Pitsis A, Anker SD, Gavazzi A, Ponikowski P, Dickstein K, Delacretaz E, Blue L, Strasser F, McMurray J; Advanced Heart Failure Study Group of the HFA of the ESC. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11:433-443
38. Swetz KM, Freeman MR, AbouEzzeddine OF, Carter KA, Boilson BA, Ottenberg AL, Park SJ, Mueller PS. Palliative medicine consultation for preparedness planning in patients receiving left ventricular assist devices as destination therapy. Mayo Clin Proc. 2011;86:493-500
39. Schwarz ER, Baraghoush A, Morrissey RP, Shah AB, Shinde AM, Phan A, Bharadwaj P. Pilot study of palliative care consultation in patients with advanced heart failure referred for cardiac transplantation. J Palliat Med. 2012;15:12-15
40. Swetz KM, Mueller PS, Ottenberg AL, Dib C, Freeman MR, Sulmasy DP. The use of advance directives among patients with left ventricular assist devices. Hosp Pract (1995). 2011;39:78-84
41. Brush S, Budge D, Alharethi R, McCormick AJ, MacPherson JE, Reid BB, Ledford ID, Smith HK, Stoker S, Clayson SE, Doty JR, Caine WT, Drakos S, Kfoury AG. End-of-life decision making and implementation in recipients of a destination left ventricular assist device. J Heart Lung Transplant. 2010;29:1337-1341
42. Hsich EM, Naftel DC, Myers SL, Gorodeski EZ, Grady KL, Schmuhl D, Ulisney KL, Young JB. Should women receive left ventricular assist device support?: findings from INTERMACS. Circ Heart Fail. 2012;5:234-240.